-
Trade Policy and the Fight Against Coronavirus
The economic impact of the coronavirus or COVID-19 will be dramatic and long-lasting. Governments across the world have put in place extraordinary economic measures to support their health systems...
-
Compulsory Licensing of IP-protected Drugs: Colombia’s Panacea for Access to Better Healthcare Services?
On 30 May 2018, Colombia joined the OECD as the group’s 37th member. Prior to the country’s accession, the Colombian government implemented a number of reforms aimed at modernising its economy...
-
The European Commission’s pharmaceutical innovation incentives review is at risk of serious overreach
Philip Stevens is executive director of Geneva Network, a UK-based research organisation working on international innovation and trade policy. Over the summer, the European Commission (EC)...
-
A Race Against Time: New Data Protection Rules in the Internet Era
It was about time. Pre-internet rules on data protection were not fit for our new interconnected reality. The core institutions of the European Union have finally set in stone an agreement which...
-
E-health Solutions: is the EU Moving in the Right Direction?
Technology-based innovations are often seen as a luxury and the healthcare sector is not an exception. However, recent technological innovations, coupled with increasing broadband coverage and...
-
The Health and Future of China-EU Trade Relations
I was asked by a big Chinese news agency to provide a short comment on the health of China-EU trade relations. Here it is: Trade growth between China and the European Union in the past ten years has...